COVID-19

October 29, 2020

Rini to lead NCI study of COVID-19 in cancer patients

Brian Rini, MD, is leading a study launched by the National Cancer Institute (NCI) that will closely monitor cancer patients who acquire COVID-19 with the goal of providing highly detailed data to guide future care.

By Tom Wilemon
October 27, 2020

Study finds areas without mask requirements have larger increase in COVID-19 hospitalizations

All areas of Tennessee have seen a resurgence in hospitalized COVID-19 patients since early October, but hospitals that draw patients from counties without masking requirements are experiencing much sharper increases, according to a new analysis from researchers at Vanderbilt University Medical Center and Vanderbilt University School of Medicine.

By Jake Lowary
October 26, 2020

Pediatrician at Monroe Carell Jr. Children’s Hospital at Vanderbilt urges caution this Halloween

While most of 2020 has been pretty scary, Halloween doesn’t have to be, say experts at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

By Jessica Pasley
October 26, 2020

National Academy of Medicine addresses urgent threats of COVID-19 and climate change at annual meeting

The COVID-19 pandemic and climate change are twin calamities that cannot be resolved without global cooperation, consistent communication and leadership and urgent innovation by the scientific community.

By Bill Snyder
October 26, 2020

COVID treatment studied by VUMC gains FDA approval

Researchers at Vanderbilt University Medical Center played a key role in the development of remdesivir, the first drug approved by the U.S. Food and Drug Administration for the treatment of COVID-19.

By Bill Snyder
October 20, 2020

Ascension St. Thomas, Tristar Health, Meharry Medical College/Nashville General Hospital, Vanderbilt Health issue joint statement on COVID-19

The number of active COVID-19 cases in Tennessee is rising. In the 13 counties that comprise the Nashville Metropolitan Area, new cases have increased 50% over the last 2 weeks. We strongly urge everyone in Middle Tennessee, and all Tennesseans, to remain vigilant in their efforts to limit the spread of the virus by wearing masks, washing hands and staying socially distant — including not participating in large gatherings.

By VUMC News and Communications
October 16, 2020

Clinical trial to test HIV drugs to treat COVID-19

Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.
By Bill Snyder
October 15, 2020

Possible COVID-19 “decoy”

It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection.
By Bill Snyder
October 14, 2020

THA honors VUMC efforts in remdesivir distribution

A team of pharmacists and physicians from Vanderbilt University Medical Center that this spring took on statewide distribution of remdesivir, an urgently needed investigational drug for severely ill patients hospitalized with COVID-19, has received the President’s Award from the Tennessee Hospital Association (THA).
By Bill Snyder
October 13, 2020

COVID-19 long-acting antibodies discovered by Vanderbilt University Medical Center move to phase 3 clinical trials

AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca.
By Bill Snyder
October 8, 2020

Undiagnosed Diseases Network continues to excel despite pandemic

Though the COVID-19 pandemic halted in-person patient visits at Undiagnosed Diseases Network (UDN) sites, including Vanderbilt University Medical Center’s, since March, groundbreaking behind-the-scenes work continues.
By Nancy Humphrey
October 8, 2020

COVID patient’s heart-lung transplant is world’s first

Vanderbilt University Medical Center has performed the world’s first dual heart-lung transplant of a COVID-19 patient.
By Matt Batcheldor
October 7, 2020

StrategyShare2020 presents thought-provoking sessions

Although the global COVID-19 pandemic forced StrategyShare2020 organizers to rapidly transform the event to an online-only format, there were no compromises in the quality and depth of the presentations, and more than 1,000 individuals registered to participate interactively, a record number for the annual event.
By Jill Clendening
1 … 20 21 22 23 24 … 40